In vivo and in vitro studies on the antioxidant activity of aloin compared to doxorubicin in rats

Drug Development Research

Volumn 73, Issue 3, 2012, Pages 154-165

  Esmat, Amr Y ^a   Said, Mahmoud M ^a   Hamdy, Germine M ^a   Soliman, Amel A ^b   Khalil, Sally A ^a  

^a Ain Shams University   (Egypt)

^b AIN SHAMS UNIVERSITY   (Egypt)

Author keywords

aloin; antioxidants; doxorubicin; heart function tests; histological studies; inducible nitric oxide synthase; rat

Indexed keywords

1,1 DIPHENYL 2 PICRYLHYDRAZYL; ALOIN; DOXORUBICIN; INDUCIBLE NITRIC OXIDE SYNTHASE; NITRIC OXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CARDIOTOXICITY; CLINICAL PROTOCOL; CONTROLLED STUDY; DRUG SYNTHESIS; HEART FUNCTION; HEART LEFT VENTRICLE; HEART MUSCLE; HISTOPATHOLOGY; IN VITRO STUDY; IN VIVO STUDY; LIPID PEROXIDATION; MALE; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; RAT; WESTERN BLOTTING;

EID: 84861101379     PISSN: 02724391     EISSN: 10982299     Source Type: Journal    
DOI: 10.1002/ddr.21006     Document Type: Article

References (60)

1. Arafa HM, Abd-Ellah MF, Hafez HF,. 2005. Abatement by naringenin of doxorubicin-induced cardiac toxicity in rats. J Egypt Natl Canc Inst 17: 291-300.
2. Arola OJ, Saraste A, Pulkki K, Kallajoki M, Parvinen M, Voipio-Pulkki LM,. 2000. Acute doxorubicin cardiotoxicity involves cardiomyocyte apoptosis. Cancer Res 60: 1782-1792.
3. Barrantes E, Guinea M,. 2003. Inhibition of collagenase and metalloproteinases by aloins and aloe gel. Life Sci 72: 843-850. (Pubitemid 35449510)
4. Beutler E, Duron O, Kelly BM,. 1963. Improved method for the determination of blood glutathione. J Lab Clin Med 61: 882-888.
5. Beyhan Ö, Elmastas M, Gedikli F,. 2010. Total phenolic compounds and antioxidant capacity of leaf, dry fruit and fresh fruit of feijoa (Acca sellowiana, Myrtaceae). J Med Plant Res 4: 1065-1072.
6. Bolaman Z, Cicek C, Kadikoylu G, Barutca S, Serter M, Yenisey C, Alper G,. 2005. The protective effects of amifostine on adriamycin-induced acute cardiotoxicity in rats. Tohoku J Exp Med 207: 249-253. (Pubitemid 41799998)
7. Bradford MM,. 1976. A rapid and sensitive method for quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254.
8. British Pharmacopoeia. 1988. Her majesty's stationery office, vol. 1. London: Published on the recommendations of the medicines commission pursuant of the medicines Act, p 24-25.
9. Brown GC, Borutaite V,. 2002. Nitric oxide inhibition of mitochondrial respiration and its role in cell death. Free Radic Biol Med 33: 1440-1450. (Pubitemid 35351587)
10. Burlew BS, Weber KT,. 2000. Connective tissue and the heart. Functional significance and regulatory mechanisms. Cardiol Clin 18: 435-442.
11. Chin DL, Lum BL, Sikic BI,. 2002. Rapid determination of PEGylated liposomal doxorubicin and its major metabolite in human plasma by ultraviolet-visible high-performance liquid chromatography. J Chromatogr B Analyt Technol Biomed Life Sci 779: 259-269. (Pubitemid 35279453)
12. Claus EP, Tyler VE, Brady LR,. 1970. Pharmacognosy. Philadelphia, PA: Lea & Febiger. 518 p.
13. Conklin KA,. 2005. Coenzyme Q10 for prevention of anthracycline induced-cardiotoxicity. Integr Cancer Ther 4: 110-130. (Pubitemid 40731561)
14. Dische Z,. 1957. Determination of pentoses. In:, Colourick SP, Kaplan NO, editors. Methods in enzymology. New York: Academic Press Inc, p 88-89.
15. Dische Z, Schwartz K,. 1954. Estimation of nucleic acids. In:, Glick D, editor. Methods of biochemical analysis. New York: Interscience Publishers Inc, p 299-300.
16. El-Habit OHM, Sayed-Ahmed MM, Gabry MS, Khalil MFK, Osman AMM,. 2000. Modulation of induced cardiocytotoxicity and genotoxicity of doxorubicin in rat by L-carnitine. J Egypt Natl Canc Inst 12: 267-274.
17. Esmat AY, El Gerzawy SM, Raafat A,. 2005. DNA ploidy and S phase fraction of breast and ovarian tumor cells treated with a natural anthracycline analog (aloin). Cancer Biol Ther 4: 108-112. (Pubitemid 41350940)
18. Esmat AY, Tomasetto C, Rio MC,. 2006. Cytotoxicity of a natural anthraquinone (aloin) against human breast cancer cell lines with and without ErbB-2-topoisomerase II alpha coamplification. Cancer Biol Ther 5: 97-103. (Pubitemid 43234985)
19. Ezz MK, Kandil EI, Said MM, Soliman AA, Esmat AY,. 2011. Cardio-protective activity of polysaccharopeptides extracted from Pleurotus ostreatus mycelium in a doxorubicin-rat model. Egypt J Biochem Mol Biol 29: 47-64.
20. Fahim FA, Abd-Allah NM, Aboul-Ela F, Esmat AY,. 1993a. Aloin: a natural anthraquinone with potential antitumor activity. J Tumor Marker Oncol 8: 27-33.
21. Fahim FA, Abd-Allah NM, Esmat AY,. 1993b. Some metabolic aspects in normal and tumour-bearing mice treated with a natural anthraquinone. J Tumor Marker Oncol 8: 35-44.
22. Fahim FA, Esmat AY, Mady EA, Amin MA,. 1997. Serum LDH and ALP isozyme activities in mice bearing solid Ehrlich carcinoma and/or treated with the maximum tolerated dose (MTD) of aloin. Dis Markers 13: 183-193. (Pubitemid 27494088)
23. Feron VJ, deGroot AP, Spanjers MT, Til HP,. 1973. Evaluation of the criterion organ weight under conditions of growth retardation. Food Cosmet Toxicol 11: 85-94.
24. Fogli S, Nieri P, Breschi MC,. 2004. The role of nitric oxide in anthracycline toxicity and prospects for pharmacologic prevention of cardiac damage. FASEB J 18: 664-675. (Pubitemid 38451788)
25. Garner AP, Paine MJI, Rodriguez-Crespo I, Chinje EC, Ortiz De Montellano P, Stratford IJ, Tew DG, Wolf CR,. 1999. Nitric oxide synthases catalyze the activation of redox cycling and bioreductive anticancer agents. Cancer Res 59: 1929-1934. (Pubitemid 29186167)
26. Garrat DC,. 1964. The quantitative analysis of drugs, vol. 3. Japan: Chapman and Hall Ltd, p 456-458.
27. Glauret AM, Lewis PR,. 1998. Biological specimen preparation for transmission electron microscopy. London: Princeton University Press.
28. Guerra J, Jesus AD, Santiago-Borrero P, Roman-Franco A, Rodriguez E, Crespo MJ,. 2005. Plasma nitric oxide levels used as an indicator of doxorubicin-induced cardiotoxicity in rats. Hematol J 5: 584-588. (Pubitemid 40309624)
29. Gutierrez JA, Clark SG, Giulumian AD, Fuchs LC,. 1997. Superoxide anions contribute to impaired regulation of blood pressure by nitric oxide during the development of cardiomyopathy. J Pharmacol Exp Ther 282: 1643-1649. (Pubitemid 27408351)
30. Injac R, Boskovic M, Perse M, Koprivec-Furlan E, Cerar A, Djordjevic A, Strukelj B,. 2008. Acute doxorubicin nephrotoxicity in rats with malignant neoplasm can be successfully treated with fullerenol C60(OH)24 via suppression of oxidative stress. Pharmacol Rep 60: 742-749.
31. Jovanović D, Djukanović LJ, Susić D, Funduk G, Jovanović Z, Dragojlović Z, Bogdanović G, Starcević-Bozović Z,. 1996. The effect of captopril on the development of adriamycin nephropathy in rats with spontaneous arterial hypertension. Srp Arh Celok Lek 124: 47-49.
32. Leblanc B, Mompon PR, Esperandieu O, Geffray B, Guillermo C,. 1991. Nuclear organizer regions in cardiac lesions induced by doxorubicin. Toxicol Pathol 19: 176-183.
33. Liu F, Ng TB,. 2000. Antioxidative and free radical scavenging activities of selected medicinal herbs. Life Sci 66: 725-735. (Pubitemid 30077865)
34. Liyana-Pathiranan CM, Shahidi F,. 2005. Antioxidant activity of commercial soft and hard wheat (Triticum aestivum L) as affected by gastric pH conditions. J Agric Food Chem 53: 2433-2440. (Pubitemid 40471721)
35. McAnulty RJ, Laurent GJ,. 1987. Collagen synthesis and degradation in vivo. Evidence for rapid rates of collagen turnover with extensive degradation of newly synthesized collagen in tissues of the adult rat. Coll Relat Res 7: 93-104.
36. Metenawy WH, Esmat AY,. 1996. Cytotoxicity of a natural anthraquinone (aloin) against breast and ovarian tumour cell lines in comparison to conventional chemotherapeutic drugs. Cancer Mol Biol 3: 851-864. (Pubitemid 27240017)
37. Minotti G, Aust SD,. 1987. The requirement for iron (III) in the initiation of lipid peroxidation by iron (II) and hydrogen peroxide. J Biol Chem 262: 1098-1104. (Pubitemid 17028419)
38. Miranda CJ, Makui H, Soares RJ, Bilodeau M, Mui J, Vali H, Bertrand R, Andrews NC, Santos MM,. 2003. Hfe deficiency increases susceptibility to cardiotoxicity and exacerbates changes in iron metabolism induced by doxorubicin. Blood 102: 2574-2580. (Pubitemid 37193598)
39. Miranda KM, Espey MG, Wink DA,. 2001. A rapid, simple spectrophotometric method for simultaneous detection of nitrate and nitrite. Nitric Oxide 5: 62-71. (Pubitemid 34146173)
40. Mordente A, Meucci E, Martorana GE, Giardina B, Minotti G,. 2001. Human heart cytosolic reductases and anthracycline cardiotoxicity. IUBMB Life 52: 83-88. (Pubitemid 33769675)
41. Mukherjee S, Banerjee SK, Maulik M, Dinda AK, Talwar KK, Maulik SK,. 2003. Protection against acute adriamycin-induced cardiotoxicity by garlic: role of endogenous antioxidants and inhibition of TNF-alpha expression. BMC Pharmacol 20: 3-16.
42. Neilan TG, Blake SL, Ichinose F, Raher MJ, Buys ES, Jassal DS, Furutani E, Perez-Sanz TM, Graveline A, Janssens SP, etal. 2007. Disruption of nitric oxide synthase-3 protects against the cardiac injury, dysfunction and mortality induced by doxorubicin. Circulation 116: 506-514. (Pubitemid 47450259)
43. Niehaus WG Jr., Samuelsson B,. 1968. Formation of malonaldehyde from phospholipid arachidonate during microsomal lipid peroxidation. Eur J Biochem 6: 126-130.
44. Olson RD, Capen CC,. 1977. Subacute cardiotoxicity of adriamycin in the rat. Lab Invest 37: 386-394.
45. Oyaizu M,. 1986. Studies on products of browning reactions: antioxidative activities of products of browning reaction prepared from glucosamine. Jpn J Nutr 44: 307-315.
46. Ozer MK, Parlakpinar H, Acet A,. 2004. Reduction of ischemia-reperfusion induced myocardial infarct size in rats by caffeic acid phenethyl ester (CAPE). Clin Biochem 37: 702-705. (Pubitemid 39078464)
47. Rajagopalan S, Politi PM, Sinha BK, Myers CE,. 1988. Adriamycin-induced free radical formation in the perfused rat heart: implications for cardiotoxicity. Cancer Res 48: 4766-4769.
48. Schneider WC,. 1945. Phosphorus compounds in animal tissues I. Extraction and estimation of desoxypentose nucleic acid and of pentose nucleic acid. J Biol Chem 161: 293-303.
49. Serrano J, Palmeira DW, Kuehl DW, Wallace KB,. 2006. Cardioselective and cumulative oxidation of mitochondrial DNA following subchronic doxorubicin administration. Biochim Biophys Acta 1411: 201-205.
50. Shad KF, Al-Salam S, Hamza AA,. 2007. Sesame oil as a protective agent against doxorubicin induced cardiotoxicity in rat. Am J Pharmacol Toxicol 2: 159-163.
51. Šimůnek T, Šterba M, Popelová O, Adamcová M, Hrdina R, Geršl V,. 2009. Anthracycline-induced cardiotoxicity: overview of studies examining the roles of oxidative stress and free cellular iron. Pharmacol Rep 61: 154-171.
52. Singh G, Singh AT, Abraham A, Bhat B, Mukherjee A, Verma R, Agarwal SK, Jha S, Mukherjee R, Burman AC,. 2008. Protective effects of Terminalia arjuna against doxorubicin-induced cardiotoxicity. J Ethnopharmacol 117: 123-129.
53. Tang SZ, Kerry JP, Sheehan D, Buckley DJ,. 2002. Antioxidative mechanism of tea catechins in chicken meat systems. Food Chem 76: 45-51. (Pubitemid 33121224)
54. Tokarska-Schlattner M, Zaugg M, da Silva R, Lucchinetti E, Schaub MC, Wallimann T, Schlattner U,. 2005. Acute toxicity of doxorubicin on isolated perfused heart: response of kinases regulating energy supply. Am J Physiol Heart Circ Physiol 289: H37-H47. (Pubitemid 40934080)
55. Towbin H, Staehelin T, Gordon J,. 1979. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A 76: 4350-4354. (Pubitemid 9256559)
56. Turko IV, Murad F,. 2002. Protein nitration in cardiovascular diseases. Pharmacol Rev 54: 619-634. (Pubitemid 35351199)
57. Vasquez-Vivar J, Martasek P, Hogg N, Masters BS, Pritchard KA Jr., Kalyanaraman B,. 1997. Endothelial nitric oxide synthase-dependent superoxide generation from adriamycin. Biochemistry 36: 11293-11297. (Pubitemid 27408610)
58. Wojtacki J, Lewicka-Nowak E, Lesniewski-Kmak K,. 2000. Anthracycline-induced cardiotoxicity: clinical course, risk factors, pathogenesis, detection and prevention - review of the literature. Med Sci Monit 6: 411-420. (Pubitemid 30313187)
59. Yi X, Bekeredjian R, DeFilipps NJ, Siddiquee Z, Fernandez E, Shohet RV,. 2006. Transcriptional analysis of doxorubicin-induced cardiotoxicity. Am J Physiol Heart Circ Physiol 290: 1098-1102.
60. Zhou Z, Kang YJ,. 2000. Cellular and subcellular localization of catalase in the heart of transgenic mice. J Histochem Cytochem 48: 585-594. (Pubitemid 30233182)